Isturisa is a medicine used to treat adults with Cushing’s syndrome, a disease characterised by an excess production of the hormone cortisol by the adrenal glands, two glands situated above the kidneys. Cushing’s syndrome is rare, and Isturisa was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 15 October 2014. Isturisa contains the active substance osilodrostat.
Therapeutic Indication
### Therapeutic indication Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adults.
Therapeutic Area (MeSH)
ATC Code
H02CA02
ATC Item
osilodrostat
Pharmacotherapeutic Group
Corticosteroids for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Isturisa
Medicine Name
Isturisa
Aliases
N/ANo risk management plan link.
